Grow Your Wealth
with Mutual Funds
HDFC Pharma And Healthcare Fund Direct-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 1,976.9 Cr.
NAV as on 24 jul, 2026
₹ 21.25
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
HDFC Pharma And Healthcare Fund Direct-growth
Inception Date
04 Oct 2023
Lock In
No Lock-in
SIP Minimum Investment amount
₹100
SWP Minimum Investment amount
₹100
STP Minimum Investment amount
₹500
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
97.25%
Cash
2.75%
Portfolio Updated on: 10 Jul, 2026
Sector Allocations
Equity
Healthcare
Industrials
Portfolio Updated on: 24 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.79% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.70% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.70% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.20% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.81% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.39% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.47% |
Debt & Credit Risk Analysis
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 15.44% | NA | 6.12% |
| 6 Months | 26.00% | NA | 12.92% |
| 9 Months | 20.05% | NA | 4.47% |
| 1 Year | 17.65% | 17.65% | 6.04% |
| 2 Years | 50.23% | 22.57% | 24.93% |
HDFC Pharma And Healthcare Fund Direct-growth is one Equity mutual fund offered by HDFC Mutual Fund. Launched on 04 Oct 2023, the fund aims To generate long-term capital appreciation Investment predominantly in equity & equity related instruments of Pharma and healthcare companies. It manages assets worth ₹1,976.9 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.94%.
Nikhil Mathur has experience Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY
Dhruv Muchhal has experience Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| SBI Healthcare Opportunities Fund-idcw | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-idcw | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from HDFC Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| HDFC Pharma And Healthcare Fund Regular-growth | 1,976.9 | +2.06% | +15.13% | +25.30% | +16.31% | — | — |
| HDFC Pharma And Healthcare Fund Regular-idcw | 1,976.9 | +2.06% | +15.13% | +25.30% | +16.31% | — | — |
| HDFC Pharma And Healthcare Fund Direct-idcw | 1,976.9 | +2.15% | +15.44% | +26.00% | +17.65% | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹574.88 | +23.77% | +17.21% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹399.41 | +23.77% | +17.21% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹46.62 | +24.54% | +16.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.15 | +24.54% | +16.25% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹496.93 | +22.49% | +15.98% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹313.04 | +22.49% | +15.98% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.04 | +21.75% | +15.57% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 24 Jul 2026 | ₹21.25 |
| 23 Jul 2026 | ₹21.30 |
| 22 Jul 2026 | ₹21.45 |
| 21 Jul 2026 | ₹21.76 |
| 20 Jul 2026 | ₹21.72 |
| 17 Jul 2026 | ₹21.51 |
| 16 Jul 2026 | ₹21.70 |
| 15 Jul 2026 | ₹21.67 |
| 14 Jul 2026 | ₹21.49 |
| 13 Jul 2026 | ₹21.36 |
| 10 Jul 2026 | ₹21.35 |
| 09 Jul 2026 | ₹21.31 |
| 08 Jul 2026 | ₹20.99 |
| 07 Jul 2026 | ₹21.22 |
| 06 Jul 2026 | ₹21.39 |
| 03 Jul 2026 | ₹21.41 |
| 02 Jul 2026 | ₹21.22 |
| 01 Jul 2026 | ₹21.03 |
| 30 Jun 2026 | ₹21.08 |
| 29 Jun 2026 | ₹20.92 |
| 25 Jun 2026 | ₹20.75 |
| 24 Jun 2026 | ₹20.81 |
| 23 Jun 2026 | ₹20.79 |
| 22 Jun 2026 | ₹20.66 |
| 19 Jun 2026 | ₹20.62 |
| 18 Jun 2026 | ₹20.41 |
| 17 Jun 2026 | ₹20.20 |
| 15 Jun 2026 | ₹20.17 |
| 12 Jun 2026 | ₹20.31 |
| 11 Jun 2026 | ₹20.18 |
Portfolio Updated on: 25 Jul, 2026
Fund Growth & Size Analysis
+₹1,976.9 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
HDFC Pharma And Healthcare Fund Direct-growth Returns Comparison
Compare HDFC Pharma And Healthcare Fund Direct-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
HDFC Pharma And Health....
No funds found for your search.
